Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
Date:11/7/2008

>

The Company also completed its previously announced lease termination and buyout transaction under which we received $4.1 million and successfully relocated its corporate headquarters to a more cost effective and better equipped facility."

Mr. Wilds concluded, "We are very encouraged by our achievement of important business and clinical milestones during the past quarter. By continuing to focus on partnering our lead product candidates, limiting additional drug development initiatives to those already partnered and in active collaborations, we expect that the net proceeds from the lease buyout and our current financial resources together with continuing expense management should be sufficient to fund our operations through 2009."

Total revenues, which consist of royalty revenue from our collaboration agreements, increased 14%, or $28,834 to $236,308 for the three months ended September 30, 2008, compared to $207,474 for the same period in 2007. This increase is primarily due to higher royalty income from our relationship with Perrigo.

Total revenues decreased 55% or $968,013 to $781,435 for the nine months ended September 30, 2008, compared to $1.7 million for the same period in 2007. The higher total revenues for 2007 were primarily due to approximately $621,222 of research and development fees and licensing revenues from an agreement terminated in the first quarter of 2007.

Net income for the three months ended September 30, 2008, was $890,370 compared to a net loss of ($3.1) million for the same period in 2007. Net loss for the nine months ended September 30, 2008, decreased 55%, or $3.9 million to $3.2 million, compared with a net loss of $7.1 million for the same period in 2007. The decrease in the net loss was primarily due to the $4.0 million net gain from the termination of the lease on our corporate facility.

In May 2008, we entered into an agreement to terminate the lease of our corporate facility for $4.1 million. Un
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
3. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
4. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
7. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
8. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
10. Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio
11. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... The non-invasive & minimally invasive cardiac output monitoring devices market is estimated ... Europe is segmented as Germany , U.K., ... Rest of Europe (RoE). Germany holds ... cardiac output monitoring devices market around 35.2% in 2014 followed by France ... , Sweden , Poland , Switzerland ...
(Date:4/21/2015)... 21, 2015 Whitehall-based ... dazzling export-led growth in just 4 years. ... part in winning the Queen,s Award for Enterprise, ... Oxford PharmaGenesis. As part of the world,s first ... bring new medicines to the world in areas ...
(Date:4/21/2015)... 2015 This report analyzes the worldwide markets ... Types: Equipment for Therapeutic Apheresis, and Equipment for Donor ... Erythrocytapheresis, Plasmapheresis, Plateletpheresis, and Others. The report provides separate ... , Japan , Europe ... of World. Annual estimates and forecasts are provided for ...
Breaking Medicine Technology:European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 2European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 2Queen's Award Crowns Achievements of Fast-growing London Consultancy 3Queen's Award Crowns Achievements of Fast-growing London Consultancy 4Queen's Award Crowns Achievements of Fast-growing London Consultancy 5World Apheresis Equipment Industry 2World Apheresis Equipment Industry 3World Apheresis Equipment Industry 4World Apheresis Equipment Industry 5World Apheresis Equipment Industry 6World Apheresis Equipment Industry 7World Apheresis Equipment Industry 8World Apheresis Equipment Industry 9World Apheresis Equipment Industry 10World Apheresis Equipment Industry 11World Apheresis Equipment Industry 12World Apheresis Equipment Industry 13World Apheresis Equipment Industry 14World Apheresis Equipment Industry 15World Apheresis Equipment Industry 16World Apheresis Equipment Industry 17World Apheresis Equipment Industry 18World Apheresis Equipment Industry 19World Apheresis Equipment Industry 20World Apheresis Equipment Industry 21
... CAUSE NO. 2010-10259, , BRAD KOVNAT, ... , ... , v. ... , THE PALLADIUM FOR SURGERY- ...
... BRISBANE, Calif. , Feb. 17 InterMune, Inc. ... the fourth quarter and 12 months ended December 31, ... business activities, and previewed upcoming milestones in 2010.   , ... of InterMune said, "Fourth quarter and recent events have been ...
Cached Medicine Technology:Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 4Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 5Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 6Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 7Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 8Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 9InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 2InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 3InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 4InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 5InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 6InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 7InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 8InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 9InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 10InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 11InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights 12
(Date:4/21/2015)... The International Journal of Chronic Obstructive Pulmonary ... and its association with smoking in the Mainland China: ... from ten diverse areas ”. , As corresponding author ... of the world’s cigarettes, but the substantial increases in ... for the full eventual health consequences to be seen. ...
(Date:4/21/2015)... Francisco, CA and Orlando, FL (PRWEB) April 21, ... Behavioral Health (National Council) will honor Dina Tyler, ... Services for PREP (Prevention and Recovery in Early ... National Council Award of Excellence: Peer Specialist of ... awards ceremony, known as the Oscars of behavioral ...
(Date:4/21/2015)... Among parents of children with autism ... as fair or poor, according to a study in ... a visit to the dentist can present many challenges ... the strange smells, loud noises, and sharp tools; the ... of the whole process—not knowing what will happen and ...
(Date:4/21/2015)... The report “Sinusitis – ... on the therapeutic development for Sinusitis. The ... targets and MOAs to produce first-in-class and ... available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html . , ... in the therapeutic development for Sinusitis and ...
(Date:4/21/2015)... April 21, 2015 Wireless Analytics, ... has been recognized by the Boston Business Journal as ... ranking was announced at a recent event celebrating the ... of the fastest-growing private companies in Massachusetts. , Wireless ... the state that recorded the fastest revenue growth from ...
Breaking Medicine News(10 mins):Health News:COPD and smoking in the Mainland China published by Dove Medical Press 2Health News:COPD and smoking in the Mainland China published by Dove Medical Press 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 2Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 3Health News:The National Council for Behavioral Health Honors Felton Institute’s PREP Program Coordinator with Prestigious Peer Specialist of the Year Award 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 2Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 3Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 4Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 5Health News:Autism Awareness Month: Dental Care Tips for Children With Autism Spectrum Disorder 6Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Wireless Analytics Ranked as 25th Fastest Growing Private Company in Massachusetts 2
... ask people how much they plan to exercise, they,ll exercise morebut ... in the Journal of Consumer Research . "When people ... in a behavior (say, if the behavior is how much to ... in the next week makes them think about what they think ...
... Today, during the 89th General Session & Exhibition of ... with the 40th Annual Meeting of the American Association ... the Canadian Association for Dental Research, lead researcher Z. ... titled "Fuz is Essential for Craniofacial and Tooth Development." ...
... Today, during the 89th General Session & Exhibition ... conjunction with the 40th Annual Meeting of the American ... of the Canadian Association for Dental Research, lead researcher ... research study titled "Sealing Manifest Occlusal Caries in Permanent ...
... 17 (HealthDay News) -- It,s normal and healthy for ... housing assistance, according to a new study. The ... involves slacker young adults who refuse to grow up ... children,s development, said the researchers. They analyzed data ...
... HealthDay Reporter , THURSDAY, March 17 (HealthDay ... significantly improved the tremors, rigidity and other motor skill ... new study reports. The phase 2 study enrolled ... half randomly assigned to receive the gene therapy and ...
... Researchers at Boston University School of Medicine (BUSM), in ... new biomarker and therapeutic target for melanoma. The novel ... the process behind tumor metastasis and may allow the ... now appear online in Cancer Research . ...
Cached Medicine News:Health News:Getting healthy: When does prediction help people change their habits? 2Health News:Sealing manifest occlusal caries in permanent teeth -- 2.5-year results 2Health News:Young Adults May Need 'Safety Net' 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 2Health News:Gene Therapy May Help Reverse Parkinson's Symptoms 3Health News:Researchers discover possible biomarker and therapeutic target for melanoma 2
The Model 340DT is a new desk top pulse oximeter that was designed for continuous pulse oximetry and has visual and audible alarms to aid with patient monitoring....
... has expanded memory capabilities for overnight sleep screening., ... oxygen saturation and pulse rate data, and can ... your needs:, ,1. The Model 130 can ... a single patient, making the device ideally suited ...
... Cost-effective, portable, continuous, or ... system with alarms and an ... Home-Use and Sleep Study modes ... in the hospital or clinical ...
... The Autocorr Plus, the fourth in ... versatile pulse oximeter/ECG/Respiration Monitor, with 3 ... digital oximetry with SAC (Serial Autocorrelation) ... electroluminescent screen display provides two user ...
Medicine Products: